Loading…

Browse All Grants

44,293 grants found

Filters
Reset

Showing 141160 of 44,293 grants

Active DISCOVERY AWARD GBP
Supracellular coordination in tissue morphogenesis
Wellcome Trust Ukri-MRC United Kingdom 2025 – 2033

How organ shape is genetically encoded remains a major unresolved question in biology. All tissues arise from simple primordia that become patterned through transcriptional changes...

£321.97M
GBP
Active DIRECTED CALL GBP
An international task force to create adaptive bio-psycho-social and environmental models of sleep, circadian rhythms, and youth depression and anxiety across five continents
Wellcome Trust Murdoch Children'S Research Institute United Kingdom 2024 – 2029

Sleep and circadian rhythm disturbances (SCRD) play vital roles in the development and maintenance of depression and anxiety, especially during youth, a critical time for early pre...

£321.83M
GBP
Completed DIRECTED CALL - FULL GBP
Adaptive responses to SARS-CoV-2 variants in the context of hybrid immunity and immune impairment
Wellcome Trust University of Cape Town United Kingdom 2023 – 2025

SARS-CoV-2 evolved variants that could escape previous immunity and transmit better. This process so far culminated in the Omicron variant, which led to a global infection wave of...

£320.33M
GBP
Active RESEARCH GBP
BEST4: A Platform Trial to determine whether capsule sponge-biomarker technology reduces mortality from oesophageal cancer
National Institute for Health and Care Research University of Cambridge United Kingdom 2022 – 2035

This study has joint funding between NIHR HTA and CRUK (total funding is £6m). Oesophageal cancer (OAC) is a poor prognosis cancer, and the current clinical pathways are ineff...

£318.21M
GBP
Active CAREER DEVELOPMENT AWARD GBP
Unravelling the lipid landscape in lysosomal storage disorders and associated Parkinson's disease: insights for drug discovery
Wellcome Trust University College London United Kingdom 2025 – 2033

Genetic variants in lysosomal sphingolipid (SL) genes cause lysosomal storage disorders (LSDs) and are strongly linked to Parkinson’s disease (PD) risk. In addition to the lysosoma...

£318.19M
GBP
Active RESEARCH GRANT GBP
Understanding Society Waves 17-19 (Fieldwork Grant 1)
Economic and Social Research Council University of Essex United Kingdom 2024 – 2029

This grant is for the fieldwork costs for waves 17-19 of the main survey and waves 18-20 of the innovation panel of Understanding Society: the UK Household Longitudinal Survey (202...

£318.1M
GBP
Active CAREER DEVELOPMENT AWARD GBP
Modelling human choroid plexus development and the regulation of cerebrospinal fluid in health and disease
Wellcome Trust Ukri-MRC United Kingdom 2023 – 2031

Our brain is floating in the cerebrospinal fluid (CSF): a source of signaling factors, hormones and nutrients. The CSF is secreted by a single layer of cells called the choroid ple...

£317.93M
GBP
Active COLLABORATIVE R&D GBP
Hydrogen Aggregated UK Logistics (HyHAUL) Project
Innovate UK Hyhaul Mobility Limited United Kingdom 2024 – 2031

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because...

£317.79M
GBP
Active DIRECTED CALL GBP
VR social cognition therapy in early psychosis: effectiveness and implementation
Wellcome Trust University of Melbourne United Kingdom 2023 – 2027

As well as specific symptom clusters, psychosis effects important non-symptom domains including social cognition and social-occupational functioning. Impaired social cognitive abil...

£317.62M
GBP
Completed RESEARCH GBP
A single-blind, randomised, phase II UK multi-centre study to determine reactogenicity and immunogenicity of booster vaccination against ancestral and novel variants of SARS-CoV-2 (COV-BOOST)
National Institute for Health and Care Research University Hospital Southampton Nhs Foun... United Kingdom 2021 – 2025

The 2 vaccines which have been delivered at scale in the UK so far have been the mRNA vaccine BNT162b2 (Pfizer) and the chimpanzee adenovirus vector vaccine ChAdOx1-nCov19 (Oxford/...

£314.73M
GBP
Active MENTAL HEALTH AWARD: UNDERSTANDING ANXIETY AND TRAUMA GBP
Circadian Light Sensitivity as a Mechanism for PTSD Vulnerability
Wellcome Trust Flinders University United Kingdom 2024 – 2029

Light regulates circadian rhythms, and unhealthy light exposure patterns have negative impacts on mental health. Disrupted circadian rhythms have been associated with posttraumatic...

£313.83M
GBP
Active RESEARCH GBP
REFINE-Lung (formerly known as CONVOLUTE): A randomised open-label phase III trial of REduced Frequency pembrolizumab ImmuNothErapy for first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm frequency-response optimisation design.
National Institute for Health and Care Research Imperial College London United Kingdom 2021 – 2028

RESEARCH QUESTION: Can pembrolizumab (pembro) dose frequency be reduced without compromising efficacy in advanced non-small cell lung cancer (NSCLC)? BACKGROUND: The anti-PD1 di...

£312.8M
GBP
Active DIRECTED CALL GBP
Understanding and breaking the chain of disrupted sleep and mental disorders
Wellcome Trust University of Lausanne United Kingdom 2024 – 2029

Mental disorders will be the number one health burden of our society worldwide in 2030. The top three among these are respectively anxiety disorders, insomnia and depression, toget...

£311.92M
GBP
Active DIRECTED CALL GBP
Optimizing the Use of Oral Cholera Vaccine for Enhanced Impact: A Randomized Controlled Trial and Observational Study to Inform Vaccination Strategies in Kenya
Wellcome Trust Albert B. Sabin Vaccine Institute, Inc United Kingdom 2024 – 2027

Through a comprehensive approach that includes a randomized controlled trial, immunological analysis, and case data analysis in Kenya, our consortium will provide valuable knowledg...

£311.91M
GBP
Active RESEARCH GBP
Improving primary care antibiotic prescribing to reduce antibiotic resistant urine infections: the IPAP-UTI programme
National Institute for Health and Care Research Nhs Bristol, North Somerset and South Gl... United Kingdom 2023 – 2028

Research question The aim is to optimise UK antibiotic prescribing for urinary tract infections (UTIs) in primary care, in response to local antimicrobial resistance (AMR) trends....

£310.37M
GBP
Active INFRASTRUCTURE GBP
NIHR Royal Marsden CRF
National Institute for Health Research The Royal Marsden Nhs Foundation Trust United Kingdom 2022 – 2027

The Royal Marsden (RM) has a long tradition of driving and delivering research to change cancer care. This includes research that translates scientific discoveries into new ways of...

£310M
GBP
Active RESEARCH GBP
The Monoclonal Antibody Medications in inflammatory Arthritis: stopping or continuing in pregnancy (MAMA) trial
National Institute for Health and Care Research University of Oxford United Kingdom 2024 – 2030

Research Question In pregnant women with Autoimmune Inflammatory Arthritis (AIA) (population), does continuing biological disease modifying anti-rheumatic drugs (bDMARDs) (interve...

£308.57M
GBP
Active INFRASTRUCTURE GBP
Birmingham BRC in Inflammation
National Institute for Health Research University Hospitals Birmingham Nhs Foun... United Kingdom 2022 – 2027

The Birmingham Biomedical Research Centre (BRC) unites leading NHS and academic institutions in the UK s biggest and most diverse population centre outside London, serving ~5.7mill...

£307.18M
GBP
Active RESEARCH GRANT GBP
AI UK: Creating an International Ecosystem for Responsible AI Research and Innovation
Engineering and Physical Sciences Research Council University of Southampton United Kingdom 2023 – 2028

Artificial Intelligence (AI) can have dramatic effects on industrial sectors and societies (e.g., Generative AI, facial recognition, autonomous vehicles). AI UK will pioneer a refl...

£307.12M
GBP
Active RESEARCH GBP
Thromboprophylaxis in Lower Limb Immobilisation (TiLLI): a multicentre study comprising two linked open label phase III randomised controlled trials evaluating the effectiveness and cost effectiveness of different methods of pharmacological prophylaxis for patients with temporary lower limb immobilisation
National Institute for Health and Care Research Queen Mary University of London United Kingdom 2023 – 2028

BACKGROUND Venous thromboembolism (VTE) is a major global health burden. Many people who survive VTE suffer from longer term physical complications or psychological sequelae. Temp...

£305.88M
GBP